Analysis of interactions of lipid metabolism alleles in dyslipidemia

详细信息    查看全文

• 作者：I. V. Nikolaev ; R. V. Mulyukova…
• 关键词：dyslipidemia ; single ; nucleotide polymorphism (SNP) ; leptin ; leptin receptor ; lipoprotein lipase ; nuclear receptor
• 刊名：Russian Journal of Genetics: Applied Research
• 出版年：2015
• 出版时间：July 2015
• 年：2015
• 卷：5
• 期：4
• 页码：313-321
• 全文大小：224 KB
• 参考文献：Ahluwalia, M., Evans, M., Morris, K., et al., The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-nanve patients with type 2 diabetes, Diabetes Obes. Metab., 2002, vol. 4, no. 6, pp. 376-78.View Article PubMed
  Barros, R.P. and Gustafsson, J.A., Estrogen receptors and the metabolic network, Cell Metab., 2011, vol. 14, no. 3, pp. 289-99.View Article PubMed
  Bartsch, D., Casadio, A., Karl, K.A., Serodio, P., and Kandel, E.R., Creb1 encodes a nuclear activator, a repressor, and a cytoplasmic modulator that form a regulatory unit critical for long-term facilitation, Cell, 1998, no. 95, pp. 211-23.
  Boden, G., Role of fatty acids in the pathogenesis of insulin resistance and NIDDM, Diabetes, 1997, no. 46, pp. 3-0.
  Carrillo-Vázquez, J.P., Chimal-Vega, B., and Zamora-Lwpez, B., Structural consequences of the polymorphism Q223R in the human leptin receptor: a molecular dynamics study, Am. J. Agric. Biol. Sci., 2013, vol. 8, no. 3, pp. 239-48.View Article
  Constantin, A., Costache, G., Sima, A., et al., Leptin G-2548A and leptin receptor Q223R gene polymorphisms are not associated with obesity in Romanian subjects, Biochem. Biophys. Res. Commun., 2010, vol. 391, no. 1, pp. 282-86.View Article PubMed
  Cooper, A., Spirin, V., Schmidt, S., et al., Common singlenucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol, Am. J. Hum. Genet., 2007, no. 81, pp. 1298-303.
  Darenskaya, M.A., Kolesnikova, L.I., Bardymova, T.P., et al., Patterns of changes of parameters of lipid peroxidation in apparently healthy subjects in different periods of formation of the reproductive system, Byul. VSNTs SO RAMN, 2006, vol. 391, no. 1, pp. 282-86.
  Despres, J.P., Couillard, C., Gagnon, J., et al., Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the health, risk factors, exercise training, and genetics (heritage) family study, Arterioscler. Thromb. Vasc. Biol., 2000, vol. 20, pp. 1932-938.View Article PubMed
  Diagnostika i korrektsiya narushenii lipidnogo obmena s tsel’yu profilaktiki i lecheniya ateroskleroza. Rekomendatsii ekspertov Vserossiiskogo nauchnogo obshchestva kardiologov (chetvertyi peresmotr) (Diagnostics and correction of lipid disorders for the prevention and treatment of atherosclerosis. Experts Recommendations of the All-Russian Scientific Society of Cardiology (Fourth Revision)), Moscow, 2009.
  Duarte, S., Francischetti, E., Genelhu, V., et al., LEPR p.Q223R,beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects, Genet. Mol. Res., 2007, vol. 6, no. 4, pp. 1035-043.PubMed
  Faulds, M.H. Zhao, C., et al., The diversity of sex steroid action: regulation of metabolism by estrogen signaling, J. Endocrinol., 2012, vol 212, pp. 3-2.View Article PubMed
  Gasteiger, E., Hoogland, C., Gattiker, A., et al., Protein identification and analysis tools on the ExPASy server, in The Proteomics Protocols Handbook, Totowa: Humana Press, 2005, pp. 571-07.View Article
  Guruprasad, K., Reddy, B.V., and Pandit, M.W., Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence, Protein Eng., 1990, no. 4, pp. 155-61.
  Hayden, M.R. and Henderson, H., The molecular biology and genetics of human lipoprotein lipase, in Lipoproteins in Health and Disorder, London, 1999, pp. 132-37.
  Heinzmann, C., Kirchgessner, T., and Lusis, A., DNA polymorphism haplotypes of the human lipoprotein lipase gene, Hum. Genet., 1991, no. 86, pp. 578-84.
  Herzig, S., Hedrick, S., Morantte, I., et al., CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ, Nature, 2003, no. 426, pp. 190-93.
  Ikai, A.J., Thermostability and aliphatic index of globular proteins, J. Biochem., 1980, no. 88, pp. 1895-898.
  Jeninga, E.H., Gurnell, M., and Kalkhoven, E., Functional implications of genetic variation in human PPARG, Trends Endocrinol. Metabolism, 2009, vol. 20, no. 8, pp. 380-87.View Article
  Kathiresan, S., Melander, O., Anevski, D., et al., Polymorphisms associated with cholesterol and risk of cardiovascular events, New Eng. J. Med., 2008, no. 358, pp. 1240-249.
  Laakso, M., Gene variants, insulin resistance, and dyslipidemia, Curr. Opin. Lipidol., 2004, vol. 2, no. 15, pp. 115-20.View Article
  Langdahl, B.L., Ralston, S.H., Grant, S.F., and Eriksen, E.F., An Spl binding site polymorphism in the colia1 gene predicts osteoporotic fractures in both men and women, J. Bone Miner. Res., 1998, vol. 13, no. 9, pp. 1384-389.View Article PubMed
  Ma, Y.Q., Thomas, G.N., and Ng, M., The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients, Metabolism, 2003, vol. 52 (3), pp. 338-43.View Article PubMed
  Maniatis, T., Fritsch, E. F., and
• 作者单位：I. V. Nikolaev (1)
  R. V. Mulyukova (1)
  L. R. Kayumova (1)
  E. V. Vorobieva (1)
  V. Yu. Gorbunova (1)
  
  1. Akmulla Bashkir State Pedagogical University, Ufa, 450000, Russia
  
• 刊物主题：Human Genetics;
• 出版者：Springer US
• ISSN：2079-0600

文摘

The parameters of lipid metabolism in the spectrum of blood serum are the most commonly used indicators in clinical practice. Their disturbances (dyslipidemia) can be manifested as elevated levels of total cholesterol and triglycerides or as changes in other indices resulting from aberrations in the lipoprotein synthesis, transport or cleavage. The clinical importance of a range of metabolic disorders, defined overall as dyslipidemia, is associated primarily with a high risk of cardiovascular disease, diabetes mellitus type 2, and obesity. Here, we examined the association of certain SNPs (G2548A in the promoter region of leptin gene LEP; A223G, in the exon 4 of leptin receptor gene LEPR; T495G, in the intron 8 in lipoprotein lipase gene LPL; and C34G, in exon 8 of the peroxisome proliferator-activated nuclear receptor γ PPARG) with disruptions in lipid metabolism; and we demonstrated their cumulative contribution towards the development of dyslipidemia.